Sivan Gelley

Title: Sivan Gelley: Innovator in Modified DNase Technology

Introduction

Sivan Gelley is a notable inventor based in Kfar-Saba, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of modified DNase proteins. With a total of 2 patents to his name, Gelley is recognized for his innovative approaches to addressing medical challenges.

Latest Patents

Gelley's latest patents focus on the creation of modified DNase I proteins. These proteins are engineered with one or more amino acids modified non-cellularly, resulting in enhanced DNA hydrolytic activity. The modified DNase I protein demonstrates improved efficacy in the presence of actin compared to its non-modified counterparts. The applications of this technology include reducing DNA content in sputum and treating diseases associated with excess extracellular DNA in various bodily fluids, secretions, or tissues.

Career Highlights

Sivan Gelley is currently associated with Protalix Ltd., a company dedicated to developing innovative biopharmaceuticals. His work at Protalix has positioned him as a key player in the biotechnology sector, contributing to advancements that have the potential to improve patient outcomes.

Collaborations

Gelley collaborates with talented professionals in his field, including coworkers Yoseph Shaaltiel and Yulia Ugortsev. Their combined expertise fosters a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Sivan Gelley is a prominent inventor whose work in modified DNase technology is paving the way for new medical treatments. His contributions to biotechnology exemplify the impact of innovation in addressing complex health issues.